- $1.65bn
- $2.03bn
- BRL3.30bn
- 97
- 70
- 96
- 99
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.79 | ||
| PEG Ratio (f) | 0.61 | ||
| EPS Growth (f) | 19.1% | ||
| Dividend Yield (f) | 2.19% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.05 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 8.04 | ||
| Price to Sales | 2.63 | ||
| EV to EBITDA | 7.68 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.06% | ||
| Return on Equity | 16.56% | ||
| Operating Margin | 31.87% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | BRLm | 1,201.19 | 1,719.37 | 2,329.06 | 2,875.91 | 3,304.33 | 3,740.7 | 4,065.89 | 34.5% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +36.74 | -7.41 | +41.48 | +3.42 | +54.95 | +24.71 | +14.43 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.
Directors
- Nicolau Esteves CHM (68)
- Virgilio Deloy Capobianco Gibbon CEO (46)
- Luis Andre Blanco CFO (47)
- Julio de Angeli OTH (50)
- Felipe Argalji DRC (33)
- Daniel Borghi DRC (47)
- Sergio Mendes Botrel Coutinho DRC (42)
- Laura Carvalho DRC (38)
- Daulins Emilio DRC (47)
- Renato Esteves DRC (33)
- Miguel de Paula IND (59)
- Flavio Dias IND (44)
- Joao Paulo Faria IND (45)
- Vanessa Lopes IND (45)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- March 22nd, 2019
- Public Since
- July 19th, 2019
- No. of Employees
- 9,717
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 93,722,831
- Address
- Alameda Oscar Niemeyer, Nova Lima, 34006-056
- Web
- Phone
- +55 3135157500
- Auditors
- Ernst & Young Auditores Independentes S. S.
Upcoming Events for AFYA
Q2 2025 Afya Ltd Earnings Call
Q3 2025 Afya Ltd Earnings Release
Q3 2025 Afya Ltd Earnings Call
Similar to AFYA
17 Education & Technology
NASDAQ Global Select Market
American Public Education
NASDAQ Global Select Market
Driven Brands Holdings
NASDAQ Global Select Market
European Wax Center
NASDAQ Global Select Market
frontdoor
NASDAQ Global Select Market
FAQ
What is the Afya share price?
As of Today at 19:07 UTC, shares in Afya are trading at $17.57. This share price information is delayed by 15 minutes.
How has the Afya share price performed this year?
Shares in Afya last closed at $17.57 and the price had moved by +1.44% over the past 365 days. In terms of relative price strength the Afya share price has underperformed the S&P500 Index by -10.27% over the past year.
What are the analyst and broker recommendations for Afya?
The overall consensus recommendation for Afya is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Afya dividend yield?
The Afya dividend yield is 1.37% based on the trailing twelve month period.
Does Afya pay a dividend?
Last year, Afya paid a total dividend of BRL1.32, and it currently has a trailing dividend yield of 1.37%. We do not have any data on when Afya is to next pay dividends.
When does Afya next pay dividends?
We do not have data on when Afya is to next pay dividends. The historic dividend yield on Afya shares is currently 1.37%.
How do I buy Afya shares?
To buy shares in Afya you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Afya?
As of the previous close price of $17.57, shares in Afya had a market capitalisation of $1.65bn.
Where are Afya shares listed?
Here are the trading details for Afya:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: AFYA
What kind of share is Afya?
Based on an overall assessment of its quality, value and momentum Afya is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Afya share price forecast for 2025?
The analyst consensus target price for shares in Afya is $20.20. That is 14.96% above the last closing price of $17.57.
Analysts covering Afya currently have a consensus Earnings Per Share (EPS) forecast of BRL9.19 for the next financial year.
Find out moreWhat is the trend in the Afya share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Afya. Over the past six months, its share price has outperformed the S&P500 Index by +6.07%.
As of the last closing price of $17.57, shares in Afya were trading +2.8% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Afya PE Ratio?
The Afya PE ratio based on its reported earnings over the past 12 months is 9.79. The shares last closed at $17.57.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Afya?
Afya's management team is headed by:
- Nicolau Esteves - CHM
- Virgilio Deloy Capobianco Gibbon - CEO
- Luis Andre Blanco - CFO
- Julio de Angeli - OTH
- Felipe Argalji - DRC
- Daniel Borghi - DRC
- Sergio Mendes Botrel Coutinho - DRC
- Laura Carvalho - DRC
- Daulins Emilio - DRC
- Renato Esteves - DRC
- Miguel de Paula - IND
- Flavio Dias - IND
- Joao Paulo Faria - IND
- Vanessa Lopes - IND